Physician profile
Sean Paul
NPI 1063733137
$13,410.42
in general payments reported to CMS, 2019-2025
15 companies · $44.57 in 2025
The $44.57 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,340 · 2020: $5,147 · 2021: $1,381 · 2022: $1,004 · 2023: $2,514 · 2024: $980 · 2025: $44.57.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,539.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,538.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $6,170.43 | 2019-2025 | Xeomin |
| Allergan, INC. | $5,000.00 | 2020 | |
| Acelrx Pharmaceuticals, INC. | $671.70 | 2021-2022 | |
| Galderma Laboratories, L.P. | $314.25 | 2019-2024 | Dysport |
| Abbvie INC. | $238.77 | 2023-2024 | |
| Horizon Therapeutics Plc | $221.69 | 2020-2022 | |
| Biotissue Holdings INC. | $204.86 | 2019-2020 | |
| Carl Zeiss Meditec USA, INC. | $190.36 | 2024 | Eq Workplace |
| Johnson & Johnson Surgical Vision, INC. | $116.65 | 2024 | Tecnis Simplicity |
| Optos, INC. | $98.67 | 2021 | |
| Derma Sciences, INC. | $52.39 | 2019 | |
| Mentor Worldwide LLC | $36.09 | 2024 | Mentor Memorygel Resterilizable Gel Sizer |
| Stryker Corporation | $35.23 | 2022 | |
| Cynosure, LLC | $30.04 | 2021 | |
| Amgen INC. | $29.29 | 2024 | Tepezza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sean Paul listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.